Option chain shows key data for Genenta Science's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Genenta Science.

Genenta Science (NASDAQ:GNTA) Stock, Option Chain

Genenta Science

Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain.

News

Penny Stocks

Small Cap

Intraday Update

Markets

Movers

Trading Ideas

ADSK

AGIL

ANGH

ATGL

Alterity Therapeutics Limited - American Depositary Shares

ATHE

ATPC

CNTB

EDSA

GHRS

GNTA

GSX Techedu Inc. American Depositary Shares

GOTU

GYRE

HSCS

MIRA

PXMD

RVYL

SHOT

SPRC

TCON

THAR

URBN

Shares of Urban Outfitters, Inc. (NASDAQ: URBN) dipped during Wednesday’s session after the company reported third-quarter financial results.

Why Urban Outfitters Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Wednesday&#39;s Mid-Day Session

Pre-Market Outlook

AKTX

ALLG

ANPC

ANVS

APGN

AREB

ARQQ

ASAN

AUUD

AYLA

BBIG

CDLX

CDRO

CLAQ

CLVS

CVNA

DICE

EVEX

GSHD

HYPR

IBRX

IDAI

IDYA

IMTX

INLX

KSPN

LCID

LPTX

LSAK

MEGL

MOGU

NRBO

NTCT

NUWE

PIXY

PYPD

RBBN

REBN

RGLS

RMED

RYTM

SGML

STRC

SWTX

TRDA

TUEM

VTNR

VTYX

WETG

YOSH

Gainers


	NeuroBo Pharmaceuticals, Inc. (NASDAQ: NRBO) jumped 101.3% to settle at $0.5558 on Monday after the company announced a 1-for-30 reverse stock split.


Why Tuesday Morning Shares Tumbled 31%; Here Are 66 Biggest Movers From Yesterday

AZRE

SHPH

SPPI

Gainers


	Ventyx Biosciences, Inc.  (NASDAQ: VTYX) shares jumped 70.4% to $39.37 after Oppenheimer maintained an Outperform rating on the stock and raised its price target from $40 to $65.


Why Ventyx Biosciences Is Trading Higher By 70%, Here Are 46 Stocks Moving In Monday&#39;s Mid-Day Session

Genenta Science S.p.A. - American Depositary Shares

Genenta Science SPA

Press Releases

General

Genenta Secures Approval for Innovative Trial for Metastatic Renal Cell Cancer

Health Care

Genenta's CEO to present at the U.S. Senate meeting on "Cross-Border Investments and Strategies in the Biotechnology Sector: A Transatlantic Perspective"

ITALIAN TRADE AGENCY TO HOST "ITALY ON THE MOVE 2025" SIDE EVENT DURING J.P. MORGAN HEALTHCARE CONFERENCE

Genenta Strengthens Agreement with AGC Biologics to Boost Cell Therapy Manufacturing

TOP ITALIAN AND U.S. LIFE SCIENCES EXECUTIVES AND ITALIAN GOVERNMENT LEADERS SHARED BUSINESS SUCCESS STORIES WITH INVESTORS AT "ITALY ON THE MOVE 2025" SIDE EVENT DURING J.P. MORGAN HEALTHCARE CONFERENCE

Opinion

Oncology Breakthroughs: How Cancer Research Is Advancing in 2025

Financing

Genenta Announces €20 million ($21.9M) Financing To Expand Pipeline As Brain Tumor Trial Is Showing Promising Survival Rates

Genenta Showcases Strategic Vision at Premier Biotech Forum in Qatar

Genenta and Anemocyte announce a collaboration for the manufacturing of starting materials for cutting-edge cell-based therapies

AMGN

CELC

ONCY

TSX:ONC

Adicet Bio

Adlai Nortye Ltd. - American Depositary Shares

Adlai Nortye

Alterity Therapeutics

Connect Biopharma Holdings Limited - American Depositary Shares

Connect Biopharma Hldgs

CervoMed

Cue Biopharma

Precision BioSciences, Inc. - Common Stock

Precision BioSciences

Fortress Biotech

Gain Therapeutics

Werewolf Therapeutics, Inc. - Common Stock

Werewolf Therapeutics

InflaRx

Opus Genetics

Klotho Neurosciences, Inc. - Common Stock

Klotho Neurosciences

Kazia Therapeutics Limited - American Depositary Shares

Kazia Therapeutics

MAIA Biotechnology

MDxHealth

Metagenomi

NeuroSense Therapeutics Ltd. - Ordinary Shares

NeuroSense Therapeutics

Oncolytics Biotech

PMV Pharma

Renovaro

Repare Therapeutics

Serina Therapeutics

Senti Biosciences

Vistagen Therapeutics, Inc. - Common Stock

Vistagen Therapeutics

HC Wainwright & Co.

Roth MKM

EF Hutton

Comments

Genenta Science

Genenta Science (GNTA) Options

No option chain data available. Please try again later

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell